Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.

K Rivet Amico; Catalina Ramirez; Margaret R Caplan; Brooke Ee Montgomery; Jennifer Stewart; Sally Hodder; Shobha Swaminathan; Jing Wang; Noshima Y Darden-Tabb; Marybeth McCauley; Kenneth H Mayer; Timothy Wilkin; Raphael J Landovitz; Roy Gulick; Adaora A Adimora; HPTN 069/A5305 Study Team and HPTN Women at Risk Committee

Journal article

Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.

K Rivet Amico, Catalina Ramirez, Margaret R Caplan, Brooke Ee Montgomery, Jennifer Stewart, Sally Hodder, Shobha Swaminathan, Jing Wang, Noshima Y Darden-Tabb, Marybeth McCauley, Kenneth H Mayer, Timothy Wilkin, Raphael J Landovitz, Roy Gulick, Adaora A Adimora, HPTN 069/A5305 Study Team and HPTN Women at Risk Committee

J Int AIDS Soc | Published : 2019

DOI: 10.1002/jia2.25247

Open access

Abstract

INTRODUCTION: Limited data exist on acceptability of candidate pre-exposure prophylaxis (PrEP) regimens among US women. We evaluated PrEP experiences, attitudes and future use intentions among sexually active women who completed the US-based HIV Prevention Trials Network 069/AIDS Clinical Trials Group 5305 study. METHODS: Women participated in the study between March 2013 and November 2015. We analysed computer-assisted self-interview (CASI) surveys among 130 women and conducted in-depth interviews among a subset of 26 women from three sites. Interviews were conducted in mid/late-2015. RESULTS: Most women (57%) reported very good/excellent PrEP adherence on CASI, although 21% acknowledged ov..

View full abstract